DRG Market Assessment 보고서
질환 개요 및 예측, 역학 인텔리전스, 바이오시밀러 인텔리전스, China In-depth 등 폭넓은 시장 인텔리전스를 확인해 보세요.
Chronic Obstructive Pulmonary Disease | Unmet Need | Severe to Very Severe | US EU | 2025
The severe to very severe chronic obstructive pulmonary disease (COPD) drug market is becoming increasingly crowded as several LAMAs, LABA/ICSs, LABA/LAMAs, LABA/LAMA/ICSs, and, most recently, the…
Primary Biliary Cholangitis – Unmet Need – Unmet Need – Primary Biliary Cholangitis (US/EU)
Primary biliary cholangitis (PBC) is a rare autoimmune liver disease characterized by inflammation, progressive damage, and destruction of the interlobular bile ducts, followed by cholestasis,…
Breast Cancer – Unmet Need – Unmet Need – Metastatic Triple-Negative Breast Cancer (US/EU)
The treatment of metastatic triple-negative breast cancer is rapidly evolving with new combination therapies and biomarker-driven approaches. Immunotherapies such as Keytruda (Merck & Co.) have…
Multiple Sclerosis – Current Treatment – Current Treatment: Physician Insights – Multiple Sclerosis (EU5)
Numerous disease-modifying therapies (DMTs) have entered the multiple sclerosis (MS) disease landscape in recent years, many of them next-generation alternatives within existing classes. Most…
Atopic Dermatitis / Atopic Eczema – Unmet Need – Unmet Need – Moderate to Severe Topical-Refractory Atopic Dermatitis (US/EU)
Topical therapies such as corticosteroids and calcineurin inhibitors are the mainstay of treatment of atopic dermatitis; however, for patients with moderate to severe disease, topical options are…
Attention-Deficit / Hyperactivity Disorder | Treatment Algorithms: Claims Data Analysis | Adult | US | 2025
Attention-deficit / hyperactivity disorder (ADHD), a common childhood mental health disorder that can persist into adulthood, affects about 6% of U.S. adults. It is characterized by impulsivity,…
